WallStreetZenWallStreetZen

NASDAQ: VXRT
Vaxart Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for VXRT

Based on 1 analyst offering 12 month price targets for Vaxart Inc

Min Forecast
$4.00+564.45%
Avg Forecast
$4.00+564.45%
Max Forecast
$4.00+564.45%

Should I buy or sell VXRT stock?

Based on 1 analyst offering ratings for Vaxart Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VXRT stock forecasts and price targets.

VXRT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-15

1 of 1

Forecast return on equity

Is VXRT forecast to generate an efficient return?

Company
-74.22%
Industry
138.15%
Market
70.73%
VXRT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VXRT forecast to generate an efficient return on assets?

Company
-30.48%
Industry
22.58%
VXRT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VXRT earnings per share forecast

What is VXRT's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.39
Avg 2 year Forecast
-$0.38
Avg 3 year Forecast
-$0.43

VXRT revenue forecast

What is VXRT's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$34.3M+104.55%
Avg 2 year Forecast
$58.5M+249.05%
Avg 3 year Forecast
$50.2M+199.44%
VXRT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

VXRT revenue growth forecast

How is VXRT forecast to perform vs Biotechnology companies and vs the US market?

Company
47.93%
Industry
34.85%
Market
8.85%
VXRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VXRT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VXRT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VXRT$0.60$4.00+564.45%Buy
ABOS$2.27$9.33+311.15%Strong Buy
SKYE$4.49$17.40+287.53%Strong Buy
ADVM$6.64$26.25+295.33%Buy
IVA$2.65$11.00+315.09%Buy
View Top Biotech Stocks

Vaxart Stock Forecast FAQ

Is Vaxart Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VXRT) stock is to Buy VXRT stock.

Out of 1 analyst, 0 (0%) are recommending VXRT as a Strong Buy, 1 (100%) are recommending VXRT as a Buy, 0 (0%) are recommending VXRT as a Hold, 0 (0%) are recommending VXRT as a Sell, and 0 (0%) are recommending VXRT as a Strong Sell.

If you're new to stock investing, here's how to buy Vaxart stock.

What is VXRT's earnings growth forecast for 2024-2026?

(NASDAQ: VXRT) Vaxart's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.57%.

Vaxart's earnings in 2024 is -$72,338,000.On average, 3 Wall Street analysts forecast VXRT's earnings for 2024 to be -$87,966,443, with the lowest VXRT earnings forecast at -$90,991,924, and the highest VXRT earnings forecast at -$81,892,732. On average, 3 Wall Street analysts forecast VXRT's earnings for 2025 to be -$86,442,328, with the lowest VXRT earnings forecast at -$122,839,098, and the highest VXRT earnings forecast at -$61,419,549.

In 2026, VXRT is forecast to generate -$97,816,319 in earnings, with the lowest earnings forecast at -$156,961,070 and the highest earnings forecast at -$63,694,347.

What is VXRT's revenue growth forecast for 2024-2026?

(NASDAQ: VXRT) Vaxart's forecast annual revenue growth rate of 47.93% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.85%.

Vaxart's revenue in 2024 is $16,760,000.On average, 3 Wall Street analysts forecast VXRT's revenue for 2024 to be $7,798,690,361, with the lowest VXRT revenue forecast at $3,070,977,449, and the highest VXRT revenue forecast at $15,878,090,808. On average, 2 Wall Street analysts forecast VXRT's revenue for 2025 to be $13,307,568,944, with the lowest VXRT revenue forecast at $5,163,791,710, and the highest VXRT revenue forecast at $21,451,346,177.

In 2026, VXRT is forecast to generate $11,416,301,795 in revenue, with the lowest revenue forecast at $2,638,765,808 and the highest revenue forecast at $26,615,137,887.

What is VXRT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VXRT) forecast ROA is -30.48%, which is lower than the forecast US Biotechnology industry average of 22.58%.

What is VXRT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VXRT price target, the average VXRT price target is $4.00, with the highest VXRT stock price forecast at $4.00 and the lowest VXRT stock price forecast at $4.00.

The Wall Street analyst predicted that Vaxart's share price could reach $4.00 by Aug 15, 2025. The average Vaxart stock price prediction forecasts a potential upside of 564.45% from the current VXRT share price of $0.60.

What is VXRT's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: VXRT) Vaxart's current Earnings Per Share (EPS) is -$0.41. On average, analysts forecast that VXRT's EPS will be -$0.39 for 2024, with the lowest EPS forecast at -$0.40, and the highest EPS forecast at -$0.36. On average, analysts forecast that VXRT's EPS will be -$0.38 for 2025, with the lowest EPS forecast at -$0.54, and the highest EPS forecast at -$0.27. In 2026, VXRT's EPS is forecast to hit -$0.43 (min: -$0.69, max: -$0.28).

What is VXRT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VXRT) forecast ROE is -74.22%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.